Ranbaxy Pharmaceuticals Inc drugs
5 results
Amlodipine besylate (amlodipine besylate)
(Amlodipine Besylate)Ranbaxy Pharmaceuticals Inc
Usage: Amlodipine besylate is indicated for treating hypertension, chronic stable angina, vasospastic angina, and in patients with documented coronary artery disease to reduce hospitalization for angina and revascularization procedures. It can be used alone or with other antihypertensive or antianginal agents.
Cefuroxime axetil for oral suspension (cefuroxime axetil)
(Cefuroxime Axetil)Ranbaxy Pharmaceuticals Inc
Usage: Cefuroxime axetil for oral suspension is indicated for treating mild to moderate infections in pediatric patients (3 months to 12 years) due to sensitive strains of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus, including certain beta-lactamase-producing strains.
Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride)
(Cyclobenzaprine Hydrochloride)Ranbaxy Pharmaceuticals Inc
Usage: Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasms due to acute, painful musculoskeletal conditions. They should be used short-term (up to 2-3 weeks) as longer use lacks evidence of effectiveness. Not effective for spasticity in spinal conditions or cerebral palsy.
Oxycodone hcl controlled-release (oxycodone hcl controlled-release)
(Oxycodone HCl Controlled-Release)Ranbaxy Pharmaceuticals Inc
Usage: Oxycodone HCl Controlled-Release Tablets are indicated for the management of moderate to severe pain requiring continuous, long-term analgesia. They are not intended for as-needed (prn) use and should not be used for mild pain or in the immediate postoperative period unless specific criteria are met.
Topiramate (topiramate)
(Topiramate)Ranbaxy Pharmaceuticals Inc
Usage: Topiramate is indicated for initial monotherapy in patients 2 years and older with partial onset or primary generalized tonic-clonic seizures. It is also used as adjunctive therapy for adults and pediatric patients (ages 2 to 16) with partial onset or tonic-clonic seizures, and for Lennox-Gastaut syndrome.